Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 4

description

Part 5

Home > Reports > Pharma & Healthcare > Liquid Embolics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Liquid Embolics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Liquid Embolics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Pharma & Healthcare

Published: 2025-02-25

Pages: 91 Pages

Report ld: 4291000

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Description

The global market for Liquid Embolics was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

North American market for Liquid Embolics was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Liquid Embolics was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Liquid Embolics was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Liquid Embolics include Medtronic, Boston Scientific, Abbott, Cyberonics, Codman & Shurtleff, Stryker, Integra LifeSciences, InoMed, Mizuho America, RauMedic, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Liquid Embolics, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Liquid Embolics by region & country, by Type, and by Application.

The Liquid Embolics market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liquid Embolics.

Market Segmentation

  • Report Metric

  • Details

  • Report Title

  • Liquid Embolics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

  • Market Size Available for Years

  • 2025-2031

  • Global Liquid Embolics Companies Covered

  • Medtronic

    Boston Scientific

    Abbott

    Cyberonics

    Codman & Shurtleff

    Stryker

    Integra LifeSciences

    InoMed

    Mizuho America

    RauMedic

  • Global Liquid Embolics Market, by Region

  • North America (U.S., Canada, Mexico)

    Europe (Germany, France, UK, Italy, etc.)

    Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

    South America (Brazil, etc.)

    Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

  • Global Liquid Embolics Market, Segment by Type

  • Isobutyl-2-Cyanoacrylate(IBCA)

    Ethanol

    Sodium Morrhuate

    Bletilla Striata

    Others

  • Global Liquid Embolics Market, Segment by Application

  • Tumor and Brain Cancer

    Brain Arteriovenous Malformations

    Ischemic Stroke

    Brain Aneurysm

    Others

  • Forecast Units

  • Million USD

  • Report Coverage

  • Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Liquid Embolics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Liquid Embolics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Liquid Embolics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Liquid Embolics Product Introduction
    1.2 Global Liquid Embolics Market Size Forecast
        1.2.1 Global Liquid Embolics Sales Value (2020-2031)
        1.2.2 Global Liquid Embolics Sales Volume (2020-2031)
        1.2.3 Global Liquid Embolics Sales Price (2020-2031)
    1.3 Liquid Embolics Market Trends & Drivers
        1.3.1 Liquid Embolics Industry Trends
        1.3.2 Liquid Embolics Market Drivers & Opportunity
        1.3.3 Liquid Embolics Market Challenges
        1.3.4 Liquid Embolics Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered
2 Competitive Analysis by Company
    2.1 Global Liquid Embolics Players Revenue Ranking (2024)
    2.2 Global Liquid Embolics Revenue by Company (2020-2025)
    2.3 Global Liquid Embolics Players Sales Volume Ranking (2024)
    2.4 Global Liquid Embolics Sales Volume by Company Players (2020-2025)
    2.5 Global Liquid Embolics Average Price by Company (2020-2025)
    2.6 Key Manufacturers Liquid Embolics Manufacturing Base and Headquarters
    2.7 Key Manufacturers Liquid Embolics Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Liquid Embolics
    2.9 Liquid Embolics Market Competitive Analysis
        2.9.1 Liquid Embolics Market Concentration Rate (2020-2025)
        2.9.2 Global 5 and 10 Largest Manufacturers by Liquid Embolics Revenue in 2024
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid Embolics as of 2024)
    2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Isobutyl-2-Cyanoacrylate(IBCA)
        3.1.2 Ethanol
        3.1.3 Sodium Morrhuate
        3.1.4 Bletilla Striata
        3.1.5 Others
    3.2 Global Liquid Embolics Sales Value by Type
        3.2.1 Global Liquid Embolics Sales Value by Type (2020 VS 2024 VS 2031)
        3.2.2 Global Liquid Embolics Sales Value, by Type (2020-2031)
        3.2.3 Global Liquid Embolics Sales Value, by Type (%) (2020-2031)
    3.3 Global Liquid Embolics Sales Volume by Type
        3.3.1 Global Liquid Embolics Sales Volume by Type (2020 VS 2024 VS 2031)
        3.3.2 Global Liquid Embolics Sales Volume, by Type (2020-2031)
        3.3.3 Global Liquid Embolics Sales Volume, by Type (%) (2020-2031)
    3.4 Global Liquid Embolics Average Price by Type (2020-2031)
4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Tumor and Brain Cancer
        4.1.2 Brain Arteriovenous Malformations
        4.1.3 Ischemic Stroke
        4.1.4 Brain Aneurysm
        4.1.5 Others
    4.2 Global Liquid Embolics Sales Value by Application
        4.2.1 Global Liquid Embolics Sales Value by Application (2020 VS 2024 VS 2031)
        4.2.2 Global Liquid Embolics Sales Value, by Application (2020-2031)
        4.2.3 Global Liquid Embolics Sales Value, by Application (%) (2020-2031)
    4.3 Global Liquid Embolics Sales Volume by Application
        4.3.1 Global Liquid Embolics Sales Volume by Application (2020 VS 2024 VS 2031)
        4.3.2 Global Liquid Embolics Sales Volume, by Application (2020-2031)
        4.3.3 Global Liquid Embolics Sales Volume, by Application (%) (2020-2031)
    4.4 Global Liquid Embolics Average Price by Application (2020-2031)
5 Segmentation by Region
    5.1 Global Liquid Embolics Sales Value by Region
        5.1.1 Global Liquid Embolics Sales Value by Region: 2020 VS 2024 VS 2031
        5.1.2 Global Liquid Embolics Sales Value by Region (2020-2025)
        5.1.3 Global Liquid Embolics Sales Value by Region (2026-2031)
        5.1.4 Global Liquid Embolics Sales Value by Region (%), (2020-2031)
    5.2 Global Liquid Embolics Sales Volume by Region
        5.2.1 Global Liquid Embolics Sales Volume by Region: 2020 VS 2024 VS 2031
        5.2.2 Global Liquid Embolics Sales Volume by Region (2020-2025)
        5.2.3 Global Liquid Embolics Sales Volume by Region (2026-2031)
        5.2.4 Global Liquid Embolics Sales Volume by Region (%), (2020-2031)
    5.3 Global Liquid Embolics Average Price by Region (2020-2031)
    5.4 North America
        5.4.1 North America Liquid Embolics Sales Value, 2020-2031
        5.4.2 North America Liquid Embolics Sales Value by Country (%), 2024 VS 2031
    5.5 Europe
        5.5.1 Europe Liquid Embolics Sales Value, 2020-2031
        5.5.2 Europe Liquid Embolics Sales Value by Country (%), 2024 VS 2031
    5.6 Asia Pacific
        5.6.1 Asia Pacific Liquid Embolics Sales Value, 2020-2031
        5.6.2 Asia Pacific Liquid Embolics Sales Value by Region (%), 2024 VS 2031
    5.7 South America
        5.7.1 South America Liquid Embolics Sales Value, 2020-2031
        5.7.2 South America Liquid Embolics Sales Value by Country (%), 2024 VS 2031
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Liquid Embolics Sales Value, 2020-2031
        5.8.2 Middle East & Africa Liquid Embolics Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Liquid Embolics Sales Value Growth Trends, 2020 VS 2024 VS 2031
    6.2 Key Countries/Regions Liquid Embolics Sales Value
        6.2.1 Key Countries/Regions Liquid Embolics Sales Value, 2020-2031
        6.2.2 Key Countries/Regions Liquid Embolics Sales Volume, 2020-2031
    6.3 United States
        6.3.1 United States Liquid Embolics Sales Value, 2020-2031
        6.3.2 United States Liquid Embolics Sales Value by Type (%), 2024 VS 2031
        6.3.3 United States Liquid Embolics Sales Value by Application, 2024 VS 2031
    6.4 Europe
        6.4.1 Europe Liquid Embolics Sales Value, 2020-2031
        6.4.2 Europe Liquid Embolics Sales Value by Type (%), 2024 VS 2031
        6.4.3 Europe Liquid Embolics Sales Value by Application, 2024 VS 2031
    6.5 China
        6.5.1 China Liquid Embolics Sales Value, 2020-2031
        6.5.2 China Liquid Embolics Sales Value by Type (%), 2024 VS 2031
        6.5.3 China Liquid Embolics Sales Value by Application, 2024 VS 2031
    6.6 Japan
        6.6.1 Japan Liquid Embolics Sales Value, 2020-2031
        6.6.2 Japan Liquid Embolics Sales Value by Type (%), 2024 VS 2031
        6.6.3 Japan Liquid Embolics Sales Value by Application, 2024 VS 2031
    6.7 South Korea
        6.7.1 South Korea Liquid Embolics Sales Value, 2020-2031
        6.7.2 South Korea Liquid Embolics Sales Value by Type (%), 2024 VS 2031
        6.7.3 South Korea Liquid Embolics Sales Value by Application, 2024 VS 2031
    6.8 Southeast Asia
        6.8.1 Southeast Asia Liquid Embolics Sales Value, 2020-2031
        6.8.2 Southeast Asia Liquid Embolics Sales Value by Type (%), 2024 VS 2031
        6.8.3 Southeast Asia Liquid Embolics Sales Value by Application, 2024 VS 2031
    6.9 India
        6.9.1 India Liquid Embolics Sales Value, 2020-2031
        6.9.2 India Liquid Embolics Sales Value by Type (%), 2024 VS 2031
        6.9.3 India Liquid Embolics Sales Value by Application, 2024 VS 2031
7 Company Profiles
    7.1 Medtronic
        7.1.1 Medtronic Company Information
        7.1.2 Medtronic Introduction and Business Overview
        7.1.3 Medtronic Liquid Embolics Sales, Revenue, Price and Gross Margin (2020-2025)
        7.1.4 Medtronic Liquid Embolics Product Offerings
        7.1.5 Medtronic Recent Development
    7.2 Boston Scientific
        7.2.1 Boston Scientific Company Information
        7.2.2 Boston Scientific Introduction and Business Overview
        7.2.3 Boston Scientific Liquid Embolics Sales, Revenue, Price and Gross Margin (2020-2025)
        7.2.4 Boston Scientific Liquid Embolics Product Offerings
        7.2.5 Boston Scientific Recent Development
    7.3 Abbott
        7.3.1 Abbott Company Information
        7.3.2 Abbott Introduction and Business Overview
        7.3.3 Abbott Liquid Embolics Sales, Revenue, Price and Gross Margin (2020-2025)
        7.3.4 Abbott Liquid Embolics Product Offerings
        7.3.5 Abbott Recent Development
    7.4 Cyberonics
        7.4.1 Cyberonics Company Information
        7.4.2 Cyberonics Introduction and Business Overview
        7.4.3 Cyberonics Liquid Embolics Sales, Revenue, Price and Gross Margin (2020-2025)
        7.4.4 Cyberonics Liquid Embolics Product Offerings
        7.4.5 Cyberonics Recent Development
    7.5 Codman & Shurtleff
        7.5.1 Codman & Shurtleff Company Information
        7.5.2 Codman & Shurtleff Introduction and Business Overview
        7.5.3 Codman & Shurtleff Liquid Embolics Sales, Revenue, Price and Gross Margin (2020-2025)
        7.5.4 Codman & Shurtleff Liquid Embolics Product Offerings
        7.5.5 Codman & Shurtleff Recent Development
    7.6 Stryker
        7.6.1 Stryker Company Information
        7.6.2 Stryker Introduction and Business Overview
        7.6.3 Stryker Liquid Embolics Sales, Revenue, Price and Gross Margin (2020-2025)
        7.6.4 Stryker Liquid Embolics Product Offerings
        7.6.5 Stryker Recent Development
    7.7 Integra LifeSciences
        7.7.1 Integra LifeSciences Company Information
        7.7.2 Integra LifeSciences Introduction and Business Overview
        7.7.3 Integra LifeSciences Liquid Embolics Sales, Revenue, Price and Gross Margin (2020-2025)
        7.7.4 Integra LifeSciences Liquid Embolics Product Offerings
        7.7.5 Integra LifeSciences Recent Development
    7.8 InoMed
        7.8.1 InoMed Company Information
        7.8.2 InoMed Introduction and Business Overview
        7.8.3 InoMed Liquid Embolics Sales, Revenue, Price and Gross Margin (2020-2025)
        7.8.4 InoMed Liquid Embolics Product Offerings
        7.8.5 InoMed Recent Development
    7.9 Mizuho America
        7.9.1 Mizuho America Company Information
        7.9.2 Mizuho America Introduction and Business Overview
        7.9.3 Mizuho America Liquid Embolics Sales, Revenue, Price and Gross Margin (2020-2025)
        7.9.4 Mizuho America Liquid Embolics Product Offerings
        7.9.5 Mizuho America Recent Development
    7.10 RauMedic
        7.10.1 RauMedic Company Information
        7.10.2 RauMedic Introduction and Business Overview
        7.10.3 RauMedic Liquid Embolics Sales, Revenue, Price and Gross Margin (2020-2025)
        7.10.4 RauMedic Liquid Embolics Product Offerings
        7.10.5 RauMedic Recent Development
8 Industry Chain Analysis
    8.1 Liquid Embolics Industrial Chain
    8.2 Liquid Embolics Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Liquid Embolics Sales Model
        8.5.2 Sales Channel
        8.5.3 Liquid Embolics Distributors
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Liquid Embolics Market Trends
 Table 2. Liquid Embolics Market Drivers & Opportunity
 Table 3. Liquid Embolics Market Challenges
 Table 4. Liquid Embolics Market Restraints
 Table 5. Global Liquid Embolics Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Liquid Embolics Revenue Market Share by Company (2020-2025)
 Table 7. Global Liquid Embolics Sales Volume by Company (2020-2025) & (K Pcs)
 Table 8. Global Liquid Embolics Sales Volume Market Share by Company (2020-2025)
 Table 9. Global Market Liquid Embolics Price by Company (2020-2025) & (USD/Pcs)
 Table 10. Key Manufacturers Liquid Embolics Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Liquid Embolics Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Liquid Embolics
 Table 13. Global Liquid Embolics Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid Embolics as of 2024)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Liquid Embolics Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Liquid Embolics Sales Value by Type (2020-2025) & (US$ Million)
 Table 18. Global Liquid Embolics Sales Value by Type (2026-2031) & (US$ Million)
 Table 19. Global Liquid Embolics Sales Market Share in Value by Type (2020-2025)
 Table 20. Global Liquid Embolics Sales Market Share in Value by Type (2026-2031)
 Table 21. Global Liquid Embolics Sales Volume by Type: 2020 VS 2024 VS 2031 (K Pcs)
 Table 22. Global Liquid Embolics Sales Volume by Type (2020-2025) & (K Pcs)
 Table 23. Global Liquid Embolics Sales Volume by Type (2026-2031) & (K Pcs)
 Table 24. Global Liquid Embolics Sales Market Share in Volume by Type (2020-2025)
 Table 25. Global Liquid Embolics Sales Market Share in Volume by Type (2026-2031)
 Table 26. Global Liquid Embolics Price by Type (2020-2025) & (USD/Pcs)
 Table 27. Global Liquid Embolics Price by Type (2026-2031) & (USD/Pcs)
 Table 28. Global Liquid Embolics Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. Global Liquid Embolics Sales Value by Application (2020-2025) & (US$ Million)
 Table 30. Global Liquid Embolics Sales Value by Application (2026-2031) & (US$ Million)
 Table 31. Global Liquid Embolics Sales Market Share in Value by Application (2020-2025)
 Table 32. Global Liquid Embolics Sales Market Share in Value by Application (2026-2031)
 Table 33. Global Liquid Embolics Sales Volume by Application: 2020 VS 2024 VS 2031 (K Pcs)
 Table 34. Global Liquid Embolics Sales Volume by Application (2020-2025) & (K Pcs)
 Table 35. Global Liquid Embolics Sales Volume by Application (2026-2031) & (K Pcs)
 Table 36. Global Liquid Embolics Sales Market Share in Volume by Application (2020-2025)
 Table 37. Global Liquid Embolics Sales Market Share in Volume by Application (2026-2031)
 Table 38. Global Liquid Embolics Price by Application (2020-2025) & (USD/Pcs)
 Table 39. Global Liquid Embolics Price by Application (2026-2031) & (USD/Pcs)
 Table 40. Global Liquid Embolics Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 41. Global Liquid Embolics Sales Value by Region (2020-2025) & (US$ Million)
 Table 42. Global Liquid Embolics Sales Value by Region (2026-2031) & (US$ Million)
 Table 43. Global Liquid Embolics Sales Value by Region (2020-2025) & (%)
 Table 44. Global Liquid Embolics Sales Value by Region (2026-2031) & (%)
 Table 45. Global Liquid Embolics Sales Volume by Region (K Pcs): 2020 VS 2024 VS 2031
 Table 46. Global Liquid Embolics Sales Volume by Region (2020-2025) & (K Pcs)
 Table 47. Global Liquid Embolics Sales Volume by Region (2026-2031) & (K Pcs)
 Table 48. Global Liquid Embolics Sales Volume by Region (2020-2025) & (%)
 Table 49. Global Liquid Embolics Sales Volume by Region (2026-2031) & (%)
 Table 50. Global Liquid Embolics Average Price by Region (2020-2025) & (USD/Pcs)
 Table 51. Global Liquid Embolics Average Price by Region (2026-2031) & (USD/Pcs)
 Table 52. Key Countries/Regions Liquid Embolics Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 53. Key Countries/Regions Liquid Embolics Sales Value, (2020-2025) & (US$ Million)
 Table 54. Key Countries/Regions Liquid Embolics Sales Value, (2026-2031) & (US$ Million)
 Table 55. Key Countries/Regions Liquid Embolics Sales Volume, (2020-2025) & (K Pcs)
 Table 56. Key Countries/Regions Liquid Embolics Sales Volume, (2026-2031) & (K Pcs)
 Table 57. Medtronic Company Information
 Table 58. Medtronic Introduction and Business Overview
 Table 59. Medtronic Liquid Embolics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 60. Medtronic Liquid Embolics Product Offerings
 Table 61. Medtronic Recent Development
 Table 62. Boston Scientific Company Information
 Table 63. Boston Scientific Introduction and Business Overview
 Table 64. Boston Scientific Liquid Embolics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 65. Boston Scientific Liquid Embolics Product Offerings
 Table 66. Boston Scientific Recent Development
 Table 67. Abbott Company Information
 Table 68. Abbott Introduction and Business Overview
 Table 69. Abbott Liquid Embolics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 70. Abbott Liquid Embolics Product Offerings
 Table 71. Abbott Recent Development
 Table 72. Cyberonics Company Information
 Table 73. Cyberonics Introduction and Business Overview
 Table 74. Cyberonics Liquid Embolics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 75. Cyberonics Liquid Embolics Product Offerings
 Table 76. Cyberonics Recent Development
 Table 77. Codman & Shurtleff Company Information
 Table 78. Codman & Shurtleff Introduction and Business Overview
 Table 79. Codman & Shurtleff Liquid Embolics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 80. Codman & Shurtleff Liquid Embolics Product Offerings
 Table 81. Codman & Shurtleff Recent Development
 Table 82. Stryker Company Information
 Table 83. Stryker Introduction and Business Overview
 Table 84. Stryker Liquid Embolics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 85. Stryker Liquid Embolics Product Offerings
 Table 86. Stryker Recent Development
 Table 87. Integra LifeSciences Company Information
 Table 88. Integra LifeSciences Introduction and Business Overview
 Table 89. Integra LifeSciences Liquid Embolics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 90. Integra LifeSciences Liquid Embolics Product Offerings
 Table 91. Integra LifeSciences Recent Development
 Table 92. InoMed Company Information
 Table 93. InoMed Introduction and Business Overview
 Table 94. InoMed Liquid Embolics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 95. InoMed Liquid Embolics Product Offerings
 Table 96. InoMed Recent Development
 Table 97. Mizuho America Company Information
 Table 98. Mizuho America Introduction and Business Overview
 Table 99. Mizuho America Liquid Embolics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 100. Mizuho America Liquid Embolics Product Offerings
 Table 101. Mizuho America Recent Development
 Table 102. RauMedic Company Information
 Table 103. RauMedic Introduction and Business Overview
 Table 104. RauMedic Liquid Embolics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 105. RauMedic Liquid Embolics Product Offerings
 Table 106. RauMedic Recent Development
 Table 107. Key Raw Materials Lists
 Table 108. Raw Materials Key Suppliers Lists
 Table 109. Liquid Embolics Downstream Customers
 Table 110. Liquid Embolics Distributors List
 Table 111. Research Programs/Design for This Report
 Table 112. Key Data Information from Secondary Sources
 Table 113. Key Data Information from Primary Sources


List of Figures
 Figure 1. Liquid Embolics Product Picture
 Figure 2. Global Liquid Embolics Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Liquid Embolics Sales Value (2020-2031) & (US$ Million)
 Figure 4. Global Liquid Embolics Sales Volume (2020-2031) & (K Pcs)
 Figure 5. Global Liquid Embolics Sales Price (2020-2031) & (USD/Pcs)
 Figure 6. Liquid Embolics Report Years Considered
 Figure 7. Global Liquid Embolics Players Revenue Ranking (2024) & (US$ Million)
 Figure 8. Global Liquid Embolics Players Sales Volume Ranking (2024) & (K Pcs)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Liquid Embolics Revenue in 2024
 Figure 10. Liquid Embolics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 11. Isobutyl-2-Cyanoacrylate(IBCA) Picture
 Figure 12. Ethanol Picture
 Figure 13. Sodium Morrhuate Picture
 Figure 14. Bletilla Striata Picture
 Figure 15. Others Picture
 Figure 16. Global Liquid Embolics Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 17. Global Liquid Embolics Sales Value Market Share by Type, 2024 & 2031
 Figure 18. Global Liquid Embolics Sales Volume by Type (2020 VS 2024 VS 2031) & (K Pcs)
 Figure 19. Global Liquid Embolics Sales Volume Market Share by Type, 2024 & 2031
 Figure 20. Global Liquid Embolics Price by Type (2020-2031) & (USD/Pcs)
 Figure 21. Product Picture of Tumor and Brain Cancer
 Figure 22. Product Picture of Brain Arteriovenous Malformations
 Figure 23. Product Picture of Ischemic Stroke
 Figure 24. Product Picture of Brain Aneurysm
 Figure 25. Product Picture of Others
 Figure 26. Global Liquid Embolics Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 27. Global Liquid Embolics Sales Value Market Share by Application, 2024 & 2031
 Figure 28. Global Liquid Embolics Sales Volume by Application (2020 VS 2024 VS 2031) & (K Pcs)
 Figure 29. Global Liquid Embolics Sales Volume Market Share by Application, 2024 & 2031
 Figure 30. Global Liquid Embolics Price by Application (2020-2031) & (USD/Pcs)
 Figure 31. North America Liquid Embolics Sales Value (2020-2031) & (US$ Million)
 Figure 32. North America Liquid Embolics Sales Value by Country (%), 2024 VS 2031
 Figure 33. Europe Liquid Embolics Sales Value, (2020-2031) & (US$ Million)
 Figure 34. Europe Liquid Embolics Sales Value by Country (%), 2024 VS 2031
 Figure 35. Asia Pacific Liquid Embolics Sales Value, (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Liquid Embolics Sales Value by Region (%), 2024 VS 2031
 Figure 37. South America Liquid Embolics Sales Value, (2020-2031) & (US$ Million)
 Figure 38. South America Liquid Embolics Sales Value by Country (%), 2024 VS 2031
 Figure 39. Middle East & Africa Liquid Embolics Sales Value, (2020-2031) & (US$ Million)
 Figure 40. Middle East & Africa Liquid Embolics Sales Value by Country (%), 2024 VS 2031
 Figure 41. Key Countries/Regions Liquid Embolics Sales Value (%), (2020-2031)
 Figure 42. Key Countries/Regions Liquid Embolics Sales Volume (%), (2020-2031)
 Figure 43. United States Liquid Embolics Sales Value, (2020-2031) & (US$ Million)
 Figure 44. United States Liquid Embolics Sales Value by Type (%), 2024 VS 2031
 Figure 45. United States Liquid Embolics Sales Value by Application (%), 2024 VS 2031
 Figure 46. Europe Liquid Embolics Sales Value, (2020-2031) & (US$ Million)
 Figure 47. Europe Liquid Embolics Sales Value by Type (%), 2024 VS 2031
 Figure 48. Europe Liquid Embolics Sales Value by Application (%), 2024 VS 2031
 Figure 49. China Liquid Embolics Sales Value, (2020-2031) & (US$ Million)
 Figure 50. China Liquid Embolics Sales Value by Type (%), 2024 VS 2031
 Figure 51. China Liquid Embolics Sales Value by Application (%), 2024 VS 2031
 Figure 52. Japan Liquid Embolics Sales Value, (2020-2031) & (US$ Million)
 Figure 53. Japan Liquid Embolics Sales Value by Type (%), 2024 VS 2031
 Figure 54. Japan Liquid Embolics Sales Value by Application (%), 2024 VS 2031
 Figure 55. South Korea Liquid Embolics Sales Value, (2020-2031) & (US$ Million)
 Figure 56. South Korea Liquid Embolics Sales Value by Type (%), 2024 VS 2031
 Figure 57. South Korea Liquid Embolics Sales Value by Application (%), 2024 VS 2031
 Figure 58. Southeast Asia Liquid Embolics Sales Value, (2020-2031) & (US$ Million)
 Figure 59. Southeast Asia Liquid Embolics Sales Value by Type (%), 2024 VS 2031
 Figure 60. Southeast Asia Liquid Embolics Sales Value by Application (%), 2024 VS 2031
 Figure 61. India Liquid Embolics Sales Value, (2020-2031) & (US$ Million)
 Figure 62. India Liquid Embolics Sales Value by Type (%), 2024 VS 2031
 Figure 63. India Liquid Embolics Sales Value by Application (%), 2024 VS 2031
 Figure 64. Liquid Embolics Industrial Chain
 Figure 65. Liquid Embolics Manufacturing Cost Structure
 Figure 66. Channels of Distribution (Direct Sales, and Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed

Description

The global market for Liquid Embolics was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

North American market for Liquid Embolics was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Liquid Embolics was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Liquid Embolics was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Liquid Embolics include Medtronic, Boston Scientific, Abbott, Cyberonics, Codman & Shurtleff, Stryker, Integra LifeSciences, InoMed, Mizuho America, RauMedic, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Liquid Embolics, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Liquid Embolics by region & country, by Type, and by Application.

The Liquid Embolics market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liquid Embolics.

Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Liquid Embolics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Liquid Embolics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Liquid Embolics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Related Reports

Liquid Embolics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Pharma & Healthcare

Published: 2025-02-25

Pages: 91 Pages

Report ld: 4291000

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

CHOOSE LICENSE TYPE
tip

USD 3950.00

tip

USD 5925.00

tip

USD 7900.00

Add to Cart

Add to Cart

Buy Now

Buy Now

Have a question?
SIMON LEE

English

English

SIMON LEE

+1-62 6295 2442

Offline

JOHN WANG

English

English

JOHN WANG

+41 765 899 438

Offline

HITESH

English

English

HITESH

+91-86 6998 6909

Offline

TANG XIN

Japanese

Japanese

TANG XIN

+81-90 3800 9273

Offline

SUNG-BIN YOON

Korean

Korean

SUNG-BIN YOON

+82-2883 1278

Offline

YUJIE TIAN

English

English

YUJIE TIAN

+86-135-2215-3954

Offline

DAMON

Chinese

Chinese

DAMON

+86-133 1872 9947

Offline

General Email:
global@qyresearch.com
WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 19 years of vast experience

    More than 19 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now